Snow David P. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Snow David P.
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2020-02-29+4,688→ 8,893 total - Exercise/Conversion
Restricted Stock Units
2020-02-29−4,688→ 0 total→ Common Stock (4,688 underlying) - Tax Payment
Common Stock
2020-02-29$3.13/sh−1,534$4,801→ 7,359 total
Footnotes (4)
- [F1]The restricted stock units issued to the reporting person on January 30, 2019 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]As a result of reporting person's separation from the Issuer, 25% of all unvested equity accelerated in accordance with the reporting person's employment agreement and the remaining unvested equity was forfeited.